FR1451171A - Etherified and esterified derivatives of 2-o-hydroxyphenyl-oxadiazole-1, 3, 4 and process for their preparation - Google Patents

Etherified and esterified derivatives of 2-o-hydroxyphenyl-oxadiazole-1, 3, 4 and process for their preparation

Info

Publication number
FR1451171A
FR1451171A FR859535A FR859535A FR1451171A FR 1451171 A FR1451171 A FR 1451171A FR 859535 A FR859535 A FR 859535A FR 859535 A FR859535 A FR 859535A FR 1451171 A FR1451171 A FR 1451171A
Authority
FR
France
Prior art keywords
etherified
oxadiazole
hydroxyphenyl
preparation
esterified derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR859535A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JACQUES LOGEAIS SOC D EXPL DES
Laboratoires Jacques Logeais SA
Original Assignee
JACQUES LOGEAIS SOC D EXPL DES
Laboratoires Jacques Logeais SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JACQUES LOGEAIS SOC D EXPL DES, Laboratoires Jacques Logeais SA filed Critical JACQUES LOGEAIS SOC D EXPL DES
Priority to FR859535A priority Critical patent/FR1451171A/en
Application granted granted Critical
Publication of FR1451171A publication Critical patent/FR1451171A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
FR859535A 1961-04-21 1961-04-21 Etherified and esterified derivatives of 2-o-hydroxyphenyl-oxadiazole-1, 3, 4 and process for their preparation Expired FR1451171A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR859535A FR1451171A (en) 1961-04-21 1961-04-21 Etherified and esterified derivatives of 2-o-hydroxyphenyl-oxadiazole-1, 3, 4 and process for their preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR859535A FR1451171A (en) 1961-04-21 1961-04-21 Etherified and esterified derivatives of 2-o-hydroxyphenyl-oxadiazole-1, 3, 4 and process for their preparation

Publications (1)

Publication Number Publication Date
FR1451171A true FR1451171A (en) 1966-01-07

Family

ID=8753606

Family Applications (1)

Application Number Title Priority Date Filing Date
FR859535A Expired FR1451171A (en) 1961-04-21 1961-04-21 Etherified and esterified derivatives of 2-o-hydroxyphenyl-oxadiazole-1, 3, 4 and process for their preparation

Country Status (1)

Country Link
FR (1) FR1451171A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1487843A2 (en) * 2002-03-20 2004-12-22 Metabolex, Inc. Substituted phenylacetic acids
WO2019115781A1 (en) 2017-12-14 2019-06-20 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US10385028B2 (en) 2017-12-14 2019-08-20 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US10934244B2 (en) 2015-06-15 2021-03-02 Nmd Pharma A/S Compounds for use in treating neuromuscular disorders
US11147788B2 (en) 2017-12-14 2021-10-19 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US11591284B2 (en) 2017-12-14 2023-02-28 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US11730714B2 (en) 2017-12-14 2023-08-22 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1487843A2 (en) * 2002-03-20 2004-12-22 Metabolex, Inc. Substituted phenylacetic acids
JP2005520858A (en) * 2002-03-20 2005-07-14 メタボレックス， インコーポレイテッド Substituted phenylacetic acid
EP1487843A4 (en) * 2002-03-20 2010-03-10 Metabolex Inc Substituted phenylacetic acids
US10934244B2 (en) 2015-06-15 2021-03-02 Nmd Pharma A/S Compounds for use in treating neuromuscular disorders
WO2019115781A1 (en) 2017-12-14 2019-06-20 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US10385028B2 (en) 2017-12-14 2019-08-20 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US11147788B2 (en) 2017-12-14 2021-10-19 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US11591284B2 (en) 2017-12-14 2023-02-28 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US11730714B2 (en) 2017-12-14 2023-08-22 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders

Similar Documents

Publication Publication Date Title
FR1451171A (en) Etherified and esterified derivatives of 2-o-hydroxyphenyl-oxadiazole-1, 3, 4 and process for their preparation
FR1367450A (en) Process for the preparation of isothiazolyl-lithium derivatives
FR1329617A (en) New derivatives of oxazolidinone-2 and their preparation process
BE631731A (en) New hydantoin derivatives and their preparation process.
OA00880A (en) Derivatives of penicellin and their preparation process.
BE628483A (en) Acylated derivatives of 2-methyl-5-oxy-8- (beta-diethylaminoethoxy) -furo- (2 ', 3': 6.7) -chromone and process for their preparation
FR1339406A (en) Process for the preparation of novel derivatives of 6-methylergoline pi and 1, 6-dimethylergoline pi
OA00419A (en) New derivatives of asiaticoside and their preparation process.
FR1417961A (en) Process for the preparation of hydroxy-xanthone derivatives
FR1479269A (en) Process for preparing hypoxanthine and its derivatives
BE590443A (en) New derivatives of phenothiazine and their preparation process.
BE601366A (en) New derivatives of phenothiazine and their preparation process.
FR1501705A (en) 3,4-di-acyl pyridoxines and process for their preparation
FR1353074A (en) Nitro-p-phenylenediamine derivatives and process for their preparation
FR1365279A (en) Octahydroanthracene derivatives, and process for their preparation
FR1315722A (en) New steroid derivatives and their preparation process
FR1337765A (en) Dibenzocycloheptadienes derivatives and their preparation process
FR1310511A (en) New sulfanilaminopyridazine derivatives and their preparation process
FR1304896A (en) Pyrazine derivatives and process for their preparation
FR1366728A (en) New gonan derivatives and their preparation process
FR1356906A (en) New derivatives of oxadiazole-1, 3, 4 and their preparation process
FR1339151A (en) Process for the preparation of new 6-methylergoline and 1,6-dimethylergoline derivatives
FR1356578A (en) New hydantoin derivatives and their preparation process
FR82764E (en) Process for the preparation of novel derivatives of 6-methylergoline ii and of 1, 6-dimethylergoline ii
FR82765E (en) Process for the preparation of novel derivatives of 6-methylergoline ii and of 1, 6-dimethylergoline ii